Susquehanna Portfolio Strategies’s Filana Therapeutics FLNA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$170K	Sell	100,772 -106,063	-51%	-$218K	﹤0.01%	912
2025 Q4	$410K	Hold	206,835	–	–	0.01%	819
2025 Q3	$602K	Buy	206,835 +73,392	+55%	+$169K	0.01%	786
2025 Q2	$242K	Buy	+133,443	New	+$237K	0.01%	779
2025 Q1	–	Sell	-37,998	Closed	-$89.7K	–	169
2024 Q4	$89.7K	Sell	37,998 -59,053	-61%	-$1.04M	0.3%	14
2024 Q3	$2.86M	Sell	97,051 -8,375	-8%	-$193K	0.2%	113
2024 Q2	$1.3M	Hold	105,426	–	–	0.05%	257
2024 Q1	$2.14M	Sell	105,426 -4,986	-5%	-$115K	0.05%	320
2023 Q4	$2.49M	Buy	+110,412	New	+$2.33M	0.04%	386

Other funds holding FLNA

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Susquehanna Portfolio Strategies's FLNA Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its Filana Therapeutics (FLNA) stake by 51% in Q1 2026, selling an estimated $218K and leaving 100,772 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #912.

Susquehanna Portfolio Strategies first reported a position in FLNA in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.86M in Q3 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

Susquehanna Portfolio Strategies held 100,772 shares of Filana Therapeutics worth $170K as of Q1 2026.
Susquehanna Portfolio Strategies sold 106,063 Filana Therapeutics shares in Q1 2026, an estimated $218K.
Filana Therapeutics made up ﹤0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #912 holding.
Susquehanna Portfolio Strategies first reported a position in Filana Therapeutics in Q4 2023 and has held it in 9 quarters since.
Susquehanna Portfolio Strategies's Filana Therapeutics position peaked at $2.86M in Q3 2024.
101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.